Skip to Main Content

Paper Details

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
Nat Commun
13
2023
BCa, FGFR3, FGFR3-mutated BCa cells, KDM5B, Luminal, S1, advanced-stage bladder cancer, histone demethylase KDM5B, muscle-invasive bladder cancer, patients, tumor, tumors
Author NameAffiliation
Amy G RobertsonDxige Research Inc.
Amy G RobertsonDxige Research Inc.
Mauro A A CastroFederal University of Parana
Clarice S GroeneveldUniversite Paris Cite, INSERM, CNRS
Clarice S GroeneveldInstitut Curie
  • 1 - 5

Datasets

Release 1.2